Shafic Abdul Wahab El Hindi, MD
Nephrology · Louisville, KYNPI 1487979456
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $30,040 of the $44,596 with a category attached, or 67.4%. Vifor Pharma, Inc. accounts for 64.1% of it on its own, with 23 other manufacturers making up the rest. Reporting peaked in 2019 at $29,037 and has fallen 99.6% since, to $124 in 2025. Among nephrology clinicians in KY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 191 payments — averaging $233.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Vifor Pharma, Inc.$29K
- Bayer$14K
- Amgen$441
- AstraZeneca$345
- Fresenius USA Marketing, Inc.$229
- Eisai Inc.$204
- plus $1K from 18 others
What the payments were for
- Consulting fees$3,6008%
- Speaking & faculty fees$30,04067%
- Travel & lodging$6,21314%
- Food & beverage$4,72511%
- Education$180%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Vifor Pharma, Inc. | 61 | $28,591 |
| Bayer | 17 | $13,558 |
| Amgen | 17 | $441 |
| AstraZeneca(2 entities) | 21 | $345 |
| Fresenius USA Marketing, Inc. | 12 | $229 |
| Eisai Inc. | 2 | $204 |
| Akebia Therapeutics Inc | 10 | $169 |
| Travere Therapeutics, Inc. | 9 | $154 |
| Otsuka America Pharmaceutical, Inc. | 8 | $154 |
| Abbott | 1 | $139 |
| GSK | 8 | $116 |
| Nxstage Medical, Inc. | 1 | $91 |
| OPKO Pharmaceuticals, LLC | 6 | $86 |
| Boehringer Ingelheim | 4 | $76 |
| Lundbeck LLC | 3 | $51 |
| Mallinckrodt Enterprises LLC | 2 | $35 |
| Apellis Pharmaceuticals, Inc. | 1 | $30 |
| Novartis | 2 | $26 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| Mallinckrodt Hospital Products Inc. | 1 | $18 |
| Daiichi Sankyo Inc. | 1 | $18 |
| Shire North American Group Inc | 1 | $17 |
| Calliditas Therapeutics US Inc. | 1 | $14 |
| Sanofi | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Veltassa$27,854
- Kerendia$13,431
- CARDIOMEMS$139
- Tavneos$122
- LENVIMA$120
How this compares
$44,596 in reported general payments places this provider in the 95th percentile of 165 nephrology providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VeltassaPatiromer Calcium Sorbitex | 21 | $24,787 |
| Potassium Citrate ErPotassium Citrate | 14 | $2,688 |
| Sevelamer Carbonate | 14 | $1,762 |
| Bumetanide | 30 | $1,578 |
| Torsemide | 38 | $921 |
| Carvedilol | 92 | $861 |
| Losartan Potassium | 87 | $626 |
| Spironolactone | 28 | $550 |
| Amlodipine Besylate | 125 | $515 |
| Terazosin Hcl | 17 | $471 |
| Hydralazine Hcl | 16 | $337 |
| Tamsulosin Hcl | 35 | $336 |
| Potassium Chloride | 22 | $204 |
| Allopurinol | 23 | $203 |
| Furosemide | 32 | $188 |
Paid to pharmacies, not to this prescriber.
Other nephrology in Louisville
- Danny WooLouisville$427K
- Dawn CasterLouisville$193K
- Nizar AttallahLouisville$113K
- George AronoffLouisville$26K
- Jai BhimaniLouisville$10K
- Alexander AfanasyevLouisville$10K
- William DuffLouisville$9K
- Bhagwan BhimaniLouisville$7K
- Aziz ChamiLouisville$6K
- John GleasonLouisville$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.